Nyxoah today announced a significant reimbursement win through the U.S. Centers for Medicare & Medicaid Services (CMS).
Medicare payments for continuous glucose monitors (CGMs) and supplies exceeded supplier acquisition costs by $377 million (or 69%) and their total estimated costs by $70 million (or 8%) ...
AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.
In this piece, we explore reasons for creating a separate conversion factor within the MPFS, initially for advanced primary ...
4d
Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque(TM) Across Hospital and Office Settings
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ -- Caristo ...
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is ...
TipRanks on MSN
Nyxoah receives Medicare reimbursement increases for Genio
Nyxoah (NYXH) announced that the U.S. Centers for Medicare & Medicaid Services has finalized its CY26 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center Rule. Within the ...
The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback